Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report, dated May 13, 2025, discloses a specific transaction regarding the company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction executed on May 12, 2025:
- Shares Purchased: 814,534 ordinary shares
- Highest Price Paid: 406.00 pence per share
- Lowest Price Paid: 399.60 pence per share
- Volume Weighted Average Price: 403.50 pence per share
- Post-Transaction Share Capital: 9,015,909,884 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,011,829,679
Material Changes
The primary material change reported is the reduction of the company's share count through the cancellation of 814,534 shares purchased under the active buyback programme. This transaction reduces the number of shares with voting rights to 9,011,829,679.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It strictly reports a completed transaction in own shares. The document includes a standard disclaimer stating it does not constitute an offer or solicitation of an offer for securities.
Investor Verification Checklist
- Verify the total number of shares purchased to date under the March 28, 2025 buyback programme.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check subsequent filings for updates on the company's broader financial performance, as this 6-K does not contain earnings data.